Skip to main content
SpringerLink
Log in

The Treatment of Chronic Hepatitis Due to Hepatitis B Virus

  • Conference paper
Viral Hepatitis

Part of the book series: Proceedings in Life Sciences ((LIFE SCIENCES))

  • 69 Accesses

Abstract

The treatment of chronic active hepatitis due to virus B (HBV) is not as satisfactory as with other forms of chronic hepatitis. The best results follow recognition of the natural history of the disease and whether the problem is that of the infectious, virus-replicating patient or the relatively non-infectious one without viral replication (Sherlock 1985) (Fig. 1). The problem of the individual must be considered, whether it is largely infectivity, symptoms or liver failure. The mode of action of any therapeutic agent must also be understood.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bréchot C, Hadchouel M, Scotto J, Fonck M, Potet F, Vyas GN, Tiollais P (1981) State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and negative liver disease. Proc Natl Acad Sci USA 78: 3906

    Article  PubMed  Google Scholar 

  • Caruso L, Weber JN, Forster GE, Scully L, Harris TRW, Thomas HC (1985) Effects of HTLV III virus infection on replication, severity of liver disease and response to interferon in chronic hepatitis B virus carriers. J Hepatol Suppl 2: 207

    Google Scholar 

  • Craxi A, Weller IVD, Bassendine MF, Fowler MJ, Monjardino J, Thomas HC, Sherlock S (1983) Relationship between HBV-specific DNA polymerase in chronic HBV infection: factors determining selection of patients and outcome of antiviral therapy. Gut 24: 143

    Article  PubMed  CAS  Google Scholar 

  • Conn HO, Maddrey WC, Soloway RD (1982) The detrimental effects or adrenocorticosteroid therapy in HBsAg-positive chronic hepatitis: facts or artefact? Hepatology 2: 885

    Article  PubMed  CAS  Google Scholar 

  • Dusheiko G, Dibisceglie A, Bowyer S, Sachs E, Ridche EM, Schoub B, Kew M (1985) Recombinant leukocyte interferon treatment of chronic hepatitis B. Hepatology 5: 556

    Article  PubMed  CAS  Google Scholar 

  • Farci P, Karayiannis P, Smedile A, Gerin J, Thomas HC (1985) Chronic delta virus infection: response to lymphoblastoid interferon. J Hepatol 1, Suppl 2: 227

    Google Scholar 

  • Gregory PB (1984) Antivirals in chronic hepatitis B — problems of small clinical trials. Gastroenterology 86: 201

    PubMed  CAS  Google Scholar 

  • Hoofnagle JH, Hanson RG, Minuk GY, Pappas Sc, Shafer DF, Dusheiko GM, Straus SE, Popper H, Jones EA (1984) Randomized controlled trial of adenine arabinoside 5-monophosphate for chronic type B hepatitis. Gastroenterology 86: 150

    PubMed  CAS  Google Scholar 

  • Ikeda T, Lever AML, Thomas HC (1985) Deficient production of interferon alpha predispose to chronic hepatitis B infection. J Hepatol Suppl 2: 256

    Google Scholar 

  • Lok ASF, Karayiannis P, Brown D, Fowler MJ, Monjardino J, Thomas HC, Sherlock S (1984) Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication. Liver 4: 45

    PubMed  CAS  Google Scholar 

  • Lok ASF, Novick DM Karayiannis P (1986) A randomized study of the effects of adenine arabinoside 5-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication. Hepatology (in press)

    Google Scholar 

  • Nouri-Aria KT, Magrin S, Anderson GJM, Alexander GJM, Eddlestone ALWF, Williams R (1985) Interleukin-2 receptor expression before and after in vitro and interferon treatment in chronic hepatitis B virus (HBV) infection. J Hepatol Suppl 2: 298

    Google Scholar 

  • Omata M, Imazeki F, Yokosuka O, Ito Y, Uchiumi K, Mori T, Okuda K (1985) Recombinant leukocyte A interferon treatment in patients with chronic hepatitis B virus infection. Gastroenterology 88: 870

    PubMed  CAS  Google Scholar 

  • Perrillo RP, Regenstein FG, Bodicky CJ, Campbell CR, Sanders GE, Sunwoo YC (1985) Comparative efficiency of adenine arabinoside 5’-monophosphate and prednison withdrawal followed by adenine arabinoside 5’-monophosphate in the treatment of chronic active hepatitis type B. Gastroenterology 88: 780

    PubMed  CAS  Google Scholar 

  • Pones JC, Carreno V, Mora I, Gutiez G, Quiroga JA, Bartolomé J, Cortez J, Hernandez J (1985) Changes of viral markers and liver histology in patients treated during six months with recombinant interferon. J Hepatol Suppl 2: 312

    Google Scholar 

  • Robinson WS, Garcia G (1985) Interferon and hepatitis B. Hepatology 5: 336

    Article  PubMed  CAS  Google Scholar 

  • Sagnelli E, Piccino F, Manzillo G, Felaco FM, Filippini P, Maio G, Pasquale G, Izzo CM (1983) Effect of immunosuppressive therapy on HBsAg-positive active hepatitis in relation to presence or absence of HBeAg and anti-HBe. Hepatology 3: 690

    Article  PubMed  CAS  Google Scholar 

  • Scullard GH, Robinson WS, Merigan TC, Robinson WS, Gregory PB (1979) The effect of immunosuppressive therapy on hepatitis B viral infection in patients with chronic hepatitis. Gastroenterology 77: 43A

    Google Scholar 

  • Scully LJ, Shein R, Lok ASF, Thomas HC (1985) Factors determining response rate to antiviral therapy in chronic hepatitis B infection. J Hepatol Suppl 2: 328

    Google Scholar 

  • Sherlock S, Thomas HC (1983) Hepatitis B virus infection: the impact of molecular biology. Hepatology 3: 455

    Article  PubMed  CAS  Google Scholar 

  • Sherlock S, (1985) Chronic hepatitis. In: Diseases of the liver and biliary system, 7th ed, Blackwell-Mosby, Oxford St. Louis, p 295

    Google Scholar 

  • Shafritz DA, Shouval D, Sherman HI, Hadziyannis ST, Kew M (1981) Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. New Engl J Med 35: 1067

    Article  Google Scholar 

  • Smedile A, Farci P, Verme G, Caredda F, Cargnel A, Caporaso N, Dentico P, Trepo C, Opolon P, Gimson A, Vergani D, Williams R, Rizzetto M (1982) Influence of delta infection on severity of hepatitis B. Lancet 2: 945

    Article  PubMed  CAS  Google Scholar 

  • Villa E, Rubbiani L, Barchi T, Ferret I, Grisendi A, De Palma M, Bellentani S, Manenti F (1982) Susceptibility of chronic symtomless HBsAg carriers to ethanol-induced hepatic damage. Lancet ii: 1243

    Article  Google Scholar 

  • Weller IVD, Fowler MF, Monjardino J, Thomas HC (1982a) The detection of HBV-DNA in serum by molecular hybridisation—a more sensitive method for the detection of complete HBV particles. J Med Virol 9: 273

    Article  CAS  Google Scholar 

  • Weller IVD, Carreno V, Fowler MF, Monjardino J, Makinen D, Thomas HC, Sherlock S (1982b) Acyclovir inhibits hepatitis B virus replication in man. Lancet i: 273

    Article  Google Scholar 

  • Weller IVD, Bassendine MF, Craxi A, Fowler MJ, Monjardino J, Thomas HC, Sherlock S (1982c) Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5-monophosphate (ARA-AMP). Gut 23: 717

    Article  CAS  Google Scholar 

  • Weller IVD, Bassendine MF, Murray A, Craxi A, Thomas HC, Sherlock S, (1982d) The effects of prednisolone/azathioprine in chronic hepatitis B viral infection. Gut 23: 650

    Article  CAS  Google Scholar 

  • Weller IVD, Lok ASF, Mindel A, Karayiannis P, Galpin S, Monjardino J, Sherlock S, Thomas HC (1985) Randomised controlled trial of adenine arabinoside 5-monophosphate (ARA-AMP) in chronid hepatitis-B virus infection. Gut 26: 745

    Article  PubMed  CAS  Google Scholar 

  • Wu Pc, Lai CL, Lam KC, Ho J (1982) Prednisolone in HBsAg-positive chronic active hepatitis: histologic evaluation in a controlled prospective study. Hepatology 2: 777

    Article  PubMed  CAS  Google Scholar 

  • Yokosuka O, Omata M, Imazeki F, Hirota K, Mori I, Uchiumi K, Ito Y, Okuda K (1985) Combination of short-term prednisolone and adenine arabinoside in the treatment of chronic hepatitis B. A controlled study. Gastroenterology 89: 246

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Royal Free Hospital Hampstead N.W.3, School of Medicine University of London, London, UK

    S. Sherlock

Authors
  1. S. Sherlock
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Histochemistry Unit, 1st Department of Pathology Spedali Civili of Brescia, Aggregaat Hoger Onderwijs, Catholic University of Leuven, 25100, Brescia, Italy

    Francesco Callea

  2. 1st Department of Pathology, Spedali Civili of Brescia, 25100, Brescia, Italy

    Mario Zorzi (Professor of Pathology and Chairman) (Professor of Pathology and Chairman)

  3. Laboratory of Histochemistry and Cytochemistry, Catholic University of Leuven, 3000, Leuven, Belgium

    Valeer J. Desmet (Professor of Pathology) (Professor of Pathology)

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Sherlock, S. (1986). The Treatment of Chronic Hepatitis Due to Hepatitis B Virus. In: Callea, F., Zorzi, M., Desmet, V.J. (eds) Viral Hepatitis. Proceedings in Life Sciences. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71350-7_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-71350-7_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-71352-1

  • Online ISBN: 978-3-642-71350-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation